Idorsia | Search

North America

Europe

Asia

Idorsia is expanding its global footprint to reach more patients with our transformative treatments.
We conduct research, clinical development and commercial operations out of the following locations. Click the pin to find out more. Click the arrows to navigate across geographies.
Click the pin to find out more.

Hegenheimermattweg 91
4123 Allschwil
Switzerland

Headquarters of Idorsia Ltd.
Responsible for drug discovery, development, registration, production, quality assurance, safety, as well as company management and coordination.

Magnusstrasse 11
12489 Berlin
Germany

A 100% subsidiary of Idorsia Pharmaceuticals Ltd, based in Berlin, Germany
– discovers and develops synthetic carbohydrate vaccines to prevent infection.

1820 Chapel Avenue West Suite
150 Cherry Hill, NJ 08002
United States

Based in New Jersey, US
– performs clinical development on behalf of Idorsia.

Marie-Curie Str. 8
79539 Lörrach
Germany

A 100% subsidiary of Idorsia Ltd, based in Lörrach, Germany
– performs clinical development on behalf of the Group and acts as the Idorsia’s representative for obtaining regulatory approvals in the EU.

20 Eastbourne Terrace London,
W2 6LG
United Kingdom

A 100% subsidiary of Idorsia Ltd, based in London, United Kingdom
– is responsible for the Group’s marketing operations in the United Kingdom.

Paseo Castellana 79
28046 Madrid
Spain

A 100% subsidiary of Idorsia Ltd, based in Madrid, Spain
– is responsible for the Group’s marketing in Spain.

6500 TransCanada Highway suite 220
Pointe Claire, Quebec
H9R 0A5
Canada

Based in Montreal, Canada
– responsible for the Idorsia’s commercial operations in Canada.

Dachauerstr. 63
80335 München
Germany

A 100% subsidiary of Idorsia Ltd, based in Munich, Germany – is responsible for the Group’s marketing operations in Germany.

Immeuble Colisée Gardens -
Bâtiment B
8-14 Avenue de l'Arche
92 400 Courbevoie
France

A 100% subsidiary of Idorsia Ltd, based in Paris, France
– will be responsible for the Group’s marketing operations in France.

One Radnor Corporate Center, Suite 101
100 Matsonford Rd
Radnor, PA 19087
United States

Based in Radnor, Pennsylvania, US – is responsible for the commercial operations in the US.

c/o FirstOffice,
Gustav III's Boulevard 46,
69 73 Solna
Sweden

A 100% subsidiary of Idorsia Ltd, based in Stockholm, Sweden
– responsible for the Idorsia’s commercial operations in Sweden, Norway, Finland, and Denmark.

Via Fabio Filzi 25A
20124 Milan
Italy

Room 311, No. 6, Lane 368
Lushuo Road
Shanghai
China

Based in Shanghai, PRC
– performs research and development on behalf of Idorsia.

Search

Share

Location

Idorsia Pharmaceuticals Ltd

Idorsia Pharmaceuticals Ltd

Idorsia (Berlin) Pharmaceuticals GmbH

Idorsia Clinical Development US Inc.

Idorsia Pharmaceuticals Deutschland GmbH

Idorsia Pharmaceuticals UK Ltd

Idorsia Pharmaceuticals Spain S.L.

Idorsia Pharmaceuticals Canada Ltd

Idorsia Pharmaceuticals Germany GmbH

Idorsia Pharmaceuticals France SAS

Idorsia Pharmaceuticals US Inc.

Idorsia Pharmaceuticals Nordics AB

Idorsia Pharmaceuticals Italy S.r.l.

Idorsia (Shanghai) Pharmaceuticals Co., Ltd

Contact

General Contact:

Whistleblower hotline: